Human induced pluripotent stem (hiPS) cells are considered a potential source for the generation of insulin-producing pancreatic b-cells because of their differentiation capacity. In this study, we have developed a five-step xeno-free culture system to efficiently differentiate hiPS cells into insulin-producing cells in vitro. We found that a high NOGGIN concentration is crucial for specifically inducing the differentiation first into pancreatic and duodenal homeobox-1 (PDX1)-positive pancreatic progenitors and then into neurogenin 3 (NGN3)-expressing pancreatic endocrine progenitors, while suppressing the differentiation into hepatic or intestinal cells. We also found that a combination of 3-isobutyl-1-methylxanthine (IBMX), exendin-4, and nicotinamide was important for the differentiation into insulin single-positive cells that expressed various pancreatic b-cell markers. Most notably, the differentiated cells contained endogenous C-peptide pools that were released in response to various insulin secretagogues and high levels of glucose. Therefore, our results demonstrate the feasibility of generating hiPS-derived pancreatic b-cells under xeno-free conditions and highlight their potential to treat patients with type 1 diabetes.
Introduction
Diabetes is a life-long disease characterized by chronic hyperglycemia. Type 1 diabetes is caused by autoimmune destruction of insulin-producing b-cells in the pancreas and its treatment is solely dependent on insulin administration. Islet transplantation from cadaveric donors is a promising therapy for type 1 diabetes; however, due to difficulties such as the scarcity of cadaveric donors compared with the large number of diabetic patients, the low yield of transplantable islets from cadaveric pancreas, and the necessity of chronic immunosuppression (Shapiro et al., 2006; Shapiro, 2011) , alternative cell sources for the generation of insulin expressing b-cells are needed.
Human pluripotent stem cells, e.g. human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells, possess the capacity for unlimited replication and the potential to differentiate into all major somatic cell lineages (Thomson et al., 1998; Takahashi et al., 2007) . Therefore, they have great potential for use in cell therapy and drug discovery. Many studies reported the generation of pancreatic endocrine cells (ECs) in vitro from hES/ iPS cells in feeder-cell culture systems (D'Amour et al., 2006; Kroon et al., 2008; Chen et al., 2009; Kunisada et al., 2012) or feeder-free culture systems (Jiang et al., 2007a, b; Zhang et al., 2009; Rezania et al., 2012) . Studies on the differentiation of hES or iPS cells into endodermal or pancreatic cell lineages have shown that activin A, fibroblast growth factor (FGF), stimulation with retinoic acid (RA), and inhibition of hedgehog, bone morphogenetic protein (BMP), and transforming growth factor (TGF)-b signaling promote the differentiation into endodermal or pancreatic lineages (D'Amour et al., 2006; Kroon et al., 2008; Chen et al., 2009; Mfopou et al., 2010; Kunisada et al., 2012; Rezania et al., 2012) . Stepwise differentiation protocols were designed to mimic pancreatic differentiation and to successfully generate insulin (INS)-expressing cells from hES or iPS cells. However, to date, pancreatic b-like cells generated from hES/iPS cells in vitro are largely polyhormonal and exhibit limited capacity of glucosestimulated insulin secretion (GSIS), a characteristic of functionally mature b-cells (D'Amour et al., 2006; Chen et al., 2009; Zhang et al., 2009; Kunisada et al., 2012; Bruin et al., 2014) . Moreover, most of the current differentiation protocols utilize a variety of undefined animal-derived products that may have unknown effects on cell characteristics and differentiation. The potential consequences of transplanting human cells exposed to animal-derived products into patients include an increased risk of graft rejection, immunoreactions, and microbial infections, prions, and yet unidentified zoonoses (Cobo et al., 2005; Martin et al., 2005; Skottman and Hovatta, 2006) . Some reports describe protocols that involved the use of xeno-free components to generate pancreatic ECs from human pluripotent stem cells (Micallef et al., 2012; Schulz et al., 2012) . Micallef et al. (2012) used xeno-free media; however, they also used mouse embryonic fibroblasts for passaging. Schulz et al. (2012) expanded hES cells in xeno-free media without feeder cells but they used fetal bovine serum during differentiation. Therefore, the establishment of a defined and completely xeno-free culture system with which functional and terminally differentiated endocrine cell types can be generated from hiPS cells is needed for future research and clinical applications.
To address these issues, we established for the first time a defined and completely xeno-free culture system to derive INSexpressing b-like cells from hiPS cells using a synthetic scaffold and serum-free media containing humanized and/or recombinant supplements and growth factors. We demonstrated that combined use of NOGGIN and 3-isobutyl-1-methylxanthine (IBMX) enhanced and directed hiPS-derived cells to differentiate into INS-expressing b-like cells. The differentiated cells secreted C-peptide in vitro in response to various insulin secretagogues and high glucose levels and expressed several pancreatic b-cell markers.
Results

Self-renewal and maintenance of undifferentiated hiPS cells under xeno-free conditions
We found that the levels of N-glycolylneuraminic acid (Neu5Gc), an indicator of xenogeneic contamination in human pluripotent stem cell cultures (Martin et al., 2005) , markedly decreased to an undetectable level in hiPS cells grown under xeno-free conditions after passage 2 (P2) ( Figure 1B) . In addition, hiPS cells grown under xenofree conditions (P3) maintained their self-renewal capacity and pluripotency, as confirmed by positive alkaline phosphatase staining and the expression levels of octamer-4 (OCT4), NANOG, SRY box-2 (SOX2), tumor rejection antigen 1-81 (TRA1-81), and stage-specific embryonic antigen-4 (SSEA-4), which were similar to those of hiPS cells grown under xenogeneic conditions (Supplementary Figure S1A) . There was no detectable expression of stage-specific embryonic antigen-1 (SSEA-1), a marker associated with hES cell differentiation, suggesting that hiPS cells maintained the undifferentiated state under xenofree conditions. HiPS cells grown under xeno-free conditions also exhibited a distinctive morphology of sharp-edged, flat, and tightly packed colony structures (Supplementary Figure S1B) , characteristic of pluripotent stem cells. Therefore, our xeno-free system is effective for keeping hiPS cells free of contamination from non-human-derived factors, while maintaining their pluripotency.
Differentiation into pancreatic progenitor cells at high NOGGIN concentrations
We developed a five-step protocol for the differentiation of hiPS cells into pancreatic hormone-expressing cells under xeno-free conditions ( Figure 2A ) by optimizing the protocol in a stepwise fashion. Figure 1 Maintenance of undifferentiated hiPS cells under xeno-free conditions. HiPS cells grown under xeno-free conditions showed a decreased expression of Neu5Gc after two passages. (A) Schematic drawing of the xeno-free culture system for proliferation and re-plating of undifferentiated hiPS cells. (B) The expression of Neu5Gc, a marker of xenoantigenic contamination, in undifferentiated hiPS cells grown under xenogeneic or xenofree conditions by flow cytometry. Cells were exposed to an anti-Neu5Gc antibody (orange), a control antibody (blue), or incubated without a primary antibody (red), and then stained with a secondary antibody for analysis. P, passage; Ab, antibody. Percentages of PDX1-, PDX1/HNF6-, PDX1/NKX6.1-, PDX1/SOX9-, CDX2-, and AFP-positive cells generated with NOGGIN 100, 200, and 300 ng/ml (Nog 100, Nog 200, and Nog 300) (i), and relative mRNA expressions of pancreatic, intestinal, and hepatic progenitor markers (ii) at the end of stage 3. (E) Immunocytochemistry showing the expression patterns of PDX1-(red, pancreatic), HNF6-(green, pancreatic), NKX6.1-(green, pancreatic), SOX9-(green, pancreatic), CDX2-(green, intestinal), and AFP (green, hepatic)-positive cells generated with NOGGIN 200 ng/ml at stage 3. Cells were counterstained with DAPI (blue). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript was used as internal RNA control. Results of both immunocytochemistry and quantitative RT-PCR are presented as mean + SEM of three independent experiments (n ¼ 3). Student's t-tests were performed against the values of Nog 100 or between two discrete data sets, *P , 0.05, **P , 0.01. Scale bar, 100 mm.
At stage 1, hiPS cells were cultured in the presence of activin A (Act, a member of the TGF-b superfamily) and CHIR99021 (a GSK3b-specific inhibitor) for 2 days, followed by an additional 3 days of culture in the presence of activin A alone to induce differentiation into definitive endoderm (DE) cells. At the end of stage 1, most cells differentiated into SRY box-17 (SOX17)/forkhead box protein A2 (FOXA2)-double positive cells (71.7% + 2.8% of total cells) and expressed the transcript of the DE marker gene SOX17, whereas the expression level of the marker gene of undifferentiated hiPS cells, OCT4, was markedly decreased ( Figure 2B) .
At stage 2, fibroblast growth factor 10 (FGF10) and a sonic hedgehog signaling inhibitor, KAAD-cyclopamine (cyc), were added to allow the transition into primitive gut tube (PG) cells. We detected a large proportion of hepatocyte nuclear factor 4a (HNF4a)/ FOXA2-double positive cells (77.7% + 2.3% of total cells) and upregulation of gut-tube marker genes FOXA2, HNF1b, and HNF4a at the end of stage 2 ( Figure 2C ).
At stage 3, combined treatment with retinoic acid (RA), KAADcyclopamine, SB431542 (SB, a TGF-b type I receptor kinase inhibitor VI), and NOGGIN (Nog, a BMP signaling inhibitor) induced differentiation into pancreatic and duodenal homeobox-1 (PDX1)-positive pancreatic progenitor (PP) cells. A considerable proportion of alpha-fetoprotein (AFP)-positive hepatic, and caudal-related homeobox 2 (CDX2)-positive (mainly PDX1/CDX2-double positive) intestinal progenitors appeared when cells were treated with 100 ng/ml NOGGIN; their number was significantly reduced when cells were treated with 200 -300 ng/ml NOGGIN ( Figure 2D , upper panels). Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis also revealed that the expression of CDX2 and AFP was significantly reduced at higher concentrations of NOGGIN. However, the expression of the posterior foregut genes PDX1, hepatocyte nuclear factor-6 (HNF6), and NK-related homeobox 6.1 (NKX6.1) (Jacquemin et al., 2003; Habener et al., 2005) and that of the pancreatic dorsal bud gene homeobox HB9 (HLXB9) (Li et al., 1999) was significantly upregulated ( Figure 2D , lower panels). These results suggest that BMP signaling is inhibitory for the differentiation into pancreatic lineages and high NOGGIN concentrations resulted in the differentiation into a high proportion of PP cells. Approximately 75% of the cells were PDX1-positive, 62% were PDX1/HNF6-double positive, 63% were PDX1/NKX6.1-double positive, and 59% were PDX1/SOX9-double positive, whereas only 8% of the cells were CDX2-positive and 4% cells were AFP-positive among all 4 ′ ,6-diamidino-2-phenylindole (DAPI)-positive cells when 200 ng/ml NOGGIN was added to stage-3 media ( Figure 2D , upper panels and E), suggesting that high NOGGIN concentrations efficiently directed the differentiation into PP cells.
A high proportion of cells differentiated into neurogenin 3-positive pancreatic endocrine progenitor cells Next, we optimized stage-4 medium by exploring the effect of indolactam V (ILV, a protein kinase C activator), Alk5i (a TGF-b type I receptor kinase inhibitor II), and different doses of NOGGIN on the induction of neurogenin 3 (NGN3)-positive endocrine progenitor (EP) cells in our xeno-free system. Results of quantitative RT-PCR showed that the expression of the NGN3 transcript was significantly upregulated, whereas those of AFP and CDX2 did not change compared with stage-3 cells, when 300 nM of ILV, 5 mM of Alk5i, and 200 ng/ml of NOGGIN were added to stage-4 medium ( Figure 3A) . Immunostaining results also showed that increasing the dose of NOGGIN up to 200 ng/ml resulted in an increase in NGN3-positive cells (up to 77% of total cells) and suppression of the reappearance of AFP-and CDX2-positive cells ( Figure 3A) . Therefore, NOGGIN at a higher dose (200 ng/ml) is indispensable to direct the differentiation of PP cells into EP cells.
At stage 4, the expression levels of other EP genes such as neurogenic differentiation 1 (NEUROD1) and paired box 4 (PAX4) were also significantly increased ( Figure 3B ). Immunostaining showed that most of the NGN3-positive cells co-expressed NEUROD1 and PAX4 when treated with ILV, Alk5i, and 200 ng/ml NOGGIN ( Figure 3B ), reflecting the commitment to differentiate into EP lineages.
IBMX-induced EP cells to differentiate into INS-positive cells
We next examined the differentiation of EP cells into INSexpressing cells. First, we checked the effect of exendin-4 (Ex-4, a peptide agonist of the glucagon-like peptide 1 (GLP-1) receptor), and nicotinamide (NA), at stage 5; and observed that exendin-4 and nicotinamide together increased differentiation efficiency of EP cells into INS-expressing cells (data not shown). Therefore, we added both exendin-4 and nicotinamide to the stage-5 medium for the subsequent experiments. Then, we tested the effect of IBMX (a phosphodiesterase inhibitor), and forskolin (FRKL, an adenylate cyclase activator) at stage 5 ( Figure 4A ). Quantitative RT-PCR showed that INS expression was significantly up-regulated in the differentiated cells when IBMX or FRKL or both were added to the culture media containing exendin-4 and nicotinamide ( Figure 4B ). Under all conditions glucagon (GCG) transcript level was very low in the differentiated cells compared with that of INS. Somatostatin (SST) transcript was also significantly upregulated when FRKL or IBMX plus FRKL were added to the culture media, whereas addition of IBMX did not significantly increase SST expression in the differentiated cells. Immunostaining showed that 6%-9% of cells of the total population were hormone-positive and 5%-8% cells were C-peptide (CP)-positive, demonstrating the de novo synthesis of insulin in differentiated cells (Rajagopal et al., 2003; Hansson et al., 2004; Sipione et al., 2004) ( Figure 4C and D) . Under all applied culture conditions, only very few cells were positive for pancreatic polypeptide and amylase, which was confirmed by the very low expression levels of their transcripts in each experiment (data not shown).
Next, we evaluated the mRNA expression levels of the pancreatic b-cell markers NKX6.1, MAF-A, islet-1 (ISL-1), glucokinase (GCK), urocortin-3 (UCN3), islet amyloid polypeptide (IAPP), and SLC30A8 (ZnT8), in cells cultured under all four conditions by quantitative RT -PCR. The results showed that the expression levels of these pancreatic b-cell genes were significantly higher in IBMX-induced differentiated cells than in DMSO-induced cells ( Figure 5A ). Then, C-peptide secretion in response to glucose was assessed in differentiated cells. Only marginal amounts of C-peptide were detected at an extracellular glucose level of Immunocytochemistry showing co-expression of NGN3-positive cells (green or red) with NEUROD1 (red) and PAX4 (green) generated with Nog 200 at stage 4. Cells were counterstained with DAPI (blue). The GAPDH transcript was used as internal RNA control. Results are presented as mean + SEM of three independent experiments (n ¼ 3). Student's t-tests were performed against the values of stage-3 cells or between two discrete data sets, *P , 0.05, **P , 0.01. Scale bar, 100 mm. Percentages of hormone-, CP-, GCG-, and SST-positive cells among the total cell population at the end of stage 5. The GAPDH transcript was used as internal RNA control. Expression levels of human adult pancreas genes were calculated and defined as 100. Results of both immunocytochemistry and quantitative RT-PCR are presented as mean + SEM of three independent experiments (n ¼ 3). Student's t-tests were performed against the values of DMSO treatment unless specifically indicated, or between two discrete data sets, *P , 0.05, **P , 0.01. AP, adult pancreas. Scale bar, 2.5 mM ( Figure 5B ). In contrast, C-peptide secretion was significantly increased under all culture conditions in response to 20 mM glucose ( 2.06-, 2.74-, 2.46-, and 2.13-fold over basal level in DMSO-, IBMX-, FRKL-, and IBMX plus FRKL-induced cells, respectively). We also detected endogenous C-peptide in cells under all four conditions; the levels of endogenous C-peptide were significantly higher in IBMX-induced and FRKLinduced cells than in DMSO-induced cells ( Figure 5C ), confirming the presence of C-peptide pools in differentiated cells. We also added NOGGIN to stage-5 culture media and examined whether addition of NOGGIN could further enhance the differentiation efficiency of EP cells into INS-expressing cells (Supplementary Figure S2A) . Both quantitative RT -PCR and immunostaining demonstrated that addition of NOGGIN to stage-5 culture media decreased the expression of INS, GCG, and SST transcripts (Supplementary Figure S2B) , and also the differentiation efficiency into pancreatic endocrine-positive (CP-, GCG-, or SST-positive) cells (Supplementary Figure S2C) , respectively. Moreover, C-peptide secretion was not significantly increased in response to 20 mM glucose over basal level under these conditions (Supplementary Figure S2D) . Therefore, we excluded NOGGIN from stage-5 culture media. The GAPDH transcript was used as internal RNA control. Expression levels of human adult pancreas genes were calculated and defined as 100. Results of both quantitative RT -PCR and ELISA are presented as mean + SEM of three independent experiments (n ¼ 3). Student's t-tests were performed against the values of DMSO unless specifically indicated, or between two discrete data sets for both gene expression and C-peptide level analyses, *P , 0.05, **P , 0.01. For glucose-stimulated C-peptide secretion, t-tests were performed against the values of 2.5 mM glucose treatment, *P , 0.05, **P , 0.01. AP, adult pancreas. channel agonist, ( -)-Bay K8644, resulted in significant stimulation of C-peptide release, suggesting the presence of functional K ATP channels (Sturgess et al., 1985) and L-type voltage-dependent Ca 2+ channels (Misler et al., 1992) . The results also showed that increasing the cAMP level by using IBMX resulted in significantly increased C-peptide secretion, indicating the cells' responsiveness to cAMP, which influences insulin secretion (Prentki and Matschinsky, 1987; Pyne and Furman, 2003) . Moreover, treatment of the differentiated cells with carbachol (a muscarinic agonist) also significantly increased the secretion of C-peptide. Immunocytochemical analysis also demonstrated that 50% of all INS-or CP-positive cells co-expressed PDX1, UCN3, IAPP, and ISL1 (Supplementary Figure  S3C) . Taken together, these results suggest that a fraction of INS-expressing cells derived from this culture system possesses pancreatic b-cell like characteristics.
NOGGIN and IBMX enhanced differentiation into INS single-positive cells
We next examined the key factors that promoted and properly directed hiPS-derived cells to differentiate into INS single-positive cells. We found that the INS expression ( Figure 6A In vitro-generated INS-expressing cells were free of xenogeneic contamination
Next, we evaluated the degree of non-human-derived contamination by measuring the expression of Neu5Gc. Flow cytometry showed that the expression of Neu5Gc was below the detection limit at stage 4 and at the end of stage 5 when xeno-free culture condition was adopted ( Figure 7A-C) , indicating that our entire differentiation system is xeno-free. We also examined the pancreatic differentiation of hiPS cells on other commercially available xeno-free scaffolds, e.g. CELLstart (composed of fibronectin) and rhVTN (recombinant human vitronectin), in our xeno-free system. We observed that the cells detached from CELLstart-and rhVTNcoated surfaces and formed large clumps (data not shown). Therefore, CELLstart-and rhVTN-coated surfaces were less suitable than Synthemax-coated surfaces for long-term differentiation culture. Moreover, the differentiation efficiency into pancreatic lineages was better on Synthemax-coated surfaces than on CELLstart-or rhVTN-coated surfaces, as indicated by the significantly higher expression levels of pancreatic marker genes, i.e. PDX1, HNF6, NKX6.1, HLXB9, and INS, and significantly lower expression levels of hepatic (AFP) and intestinal (CDX2) marker genes ( Figure 7D ).
Differentiation of other human ES/iPS cell lines into INS-positive cells
Finally, we examined whether our xeno-free differentiation system could be applied to other human ES/iPS cell lines. We used KhES3, a human ES cell line, and 201B7, a human iPS cell line, and compared their differentiation efficiency into INS-expressing cells to that of Toe ( Figure 8A) . Quantitative RT -PCR showed that both KhES3-and 201B7-derived cells expressed INS, GCG, and SST transcripts, the extents of which were similar to those of Toe-derived cells ( Figure 8B) . Immunostaining results showed that both KhES3 and 201B7 cells differentiated into b-like cells ( Figure 8C) , most of which were INS single-positive like that of Toe-derived cells. We also detected endogenous C-peptide contents in both KhES3-and 201B7-derived cells, the levels of which were similar to that of Toe-derived cells ( Figure 8D ). In addition, we assessed KhES3-and 201B7-derived cells for their C-peptide secretion in response to high glucose concentration ( Figure 8E) . Results indicated that C-peptide secretion was significantly increased in both KhES3-and 201B7-derived cells in response to 20 mM glucose ( 2.12-and 2.70-fold over basal level, respectively), which were similar to that of the Toe-derived cells (2.55-fold over basal level). These results suggest that our in vitro xeno-free system is suitable for pancreatic b-cell differentiation, not only from Toe but also from other human ES/iPS cell lines.
Discussion
In this study, we established a five-step protocol and successfully generated INS-producing b-like cells from hiPS cells in vitro that possess endogenous insulin pools and secrete C-peptide in a glucose-sensitive manner. Importantly, we found that optimization of the growth factors is important for directing the differentiation into INS single-positive b-like cells. We applied humanized and/or recombinant factors, chemically defined supplements, and synthetic scaffolds in our in vitro culture system. Our protocol is simple, completely xeno-free, and does not include embryoid body formation, cell sorting, or reseeding on other plates.
We found that combined treatment with RA, KAAD-cyclopamine, SB431542, and NOGGIN was effective to induce PP cells at stage 3. Hedgehog signaling has been reported to antagonize RA-mediated specification of pancreatic ECs during zebrafish and mouse embryonic development (Martín et al., 2005; Micallef et al., 2005; Stafford et al., 2006; Tehrani and Lin, 2011) . In our differentiation system, the number of AFP-positive cells was lesser at high NOGGIN concentrations (200-300 ng/ml), which is in agreement with previous reports that showed that BMP is required for hepatic differentiation but inhibitory for pancreatic differentiation (Cai et al., 2010; Mfopou et al., 2010) . BMP signaling has also been reported to increase CDX2 expression through SMAD4 (Barros et al., 2008) , which might explain the downregulation of CDX2 at high NOGGIN concentrations.
At stage 4, we applied a combination of Alk5i, ILV, and NOGGIN and noted the efficient induction of EP cells from PP cells, which 2.5 mM glucose. Fold increases are shown on the top of each pair of bars. The GAPDH transcript was used as internal RNA control. Expression levels of human adult pancreas genes were calculated and defined as 100. Results are presented as mean + SEM (n ¼ 3). Student's t-tests were performed between two discrete data sets for both gene expression and C-peptide level analysis, *P , 0.05, **P , 0.01. For glucose-stimulated C-peptide secretion, t-tests were performed against the values of 2.5 mM glucose treatment, *P , 0.05, **P , 0.01. AP, adult pancreas. Scale bar, 100 mm.
was consistent with recent reports (Rezania et al., 2012 (Rezania et al., , 2013 . We successfully induced a high proportion of NGN3-expressing EP cells (Schwitzgebel et al., 2000; Gu et al., 2002) , most of which co-expressed NEUROD1 and PAX4. Moreover, the NGN3 transcript was highly expressed at this stage and gradually disappeared within one or two more days, which is consistent with the transient expression of this gene in vivo (Schwitzgebel et al., 2000) . NKX6.1, an important regulator of the differentiation of pancreatic ECs, in particular, of b-cells (Habener et al., 2005) , was expressed in both stage-3 and stage-4 cells, indicating that the progenitor cells derived in our culture system possess the potential to differentiate into pancreatic b-cells.
Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells (Otonkoski et al., 1993) . In contrast, GLP-1 was reported to increase pancreatic b-cell mass (Buteau et al., 2003) . Therefore, we added nicotinamide and exendin-4 (a peptide analog of the GLP-1 receptor) to the final differentiation medium. As expected, CP-expressing b-like cells appeared in the cell culture, however, to a lesser extent. Both IBMX and FRKL in addition to exendin-4 and nicotinamide further promoted differentiation into CP-expressing cells. IBMX and FRKL are known to increase the intracellular cAMP level, suggesting that the cellular cAMP level is one of the key factors that enhance the differentiation of INS-positive cells. Although IBMX and FRKL, in addition to exendin-4 and nicotinamide, similarly promoted the differentiation into CP-positive cells, we considered that the combination of exendin-4, nicotinamide, and IBMX provided a better environment for the induction of EPs to differentiate into INS-expressing cells. This assumption was based on the following observations. First, the number of SST-positive cells was relatively higher in FRKL-induced cells than in IBMX-induced cells, indicating that although both IBMX and FRKL increased the intracellular cAMP level, FRKL might promote SST-positive cells by acting on other pathways. Second, the expression levels of b-cell specific genes were relatively higher in IBMX-induced cells than in FRKL-induced cells.
The differentiated cells obtained in our culture system secreted C-peptide in a glucose-dependent manner; the amount of secreted C-peptide was 2.8 times higher than the basal level. Previous reports suggested that in vitro hES/iPS-derived INS-positive cells have a limited capacity to secrete C-peptide in a glucosedependent manner (D'Amour et al., 2006; Jiang et al., 2007a, b; Chen et al., 2009; Zhang et al., 2009; Cheng et al., 2012; Kunisada et al., 2012; Bruin et al., 2014) . Each report described varying degrees of in vitro glucose-stimulated C-peptide secretion, including an 3-fold increase (Cheng et al., 2012) , a 1.7-fold increase (Chen et al., 2009) , a 2-fold increase (Jiang et al., 2007b; Zhang et al., 2009) , a 3.2-fold increase (Jiang et al., 2007a) , and apparently no glucose-stimulated C-peptide secretion (D'Amour et al., 2006; Kunisada et al., 2012; Bruin et al., 2014) . These variations , cultured under xenogeneic (gray bars) or xeno-free (black bars) conditions. Cells were exposed to an anti-Neu5Gc antibody (orange), a negative control antibody (blue), or incubated without primary antibody (red), and then stained with a secondary antibody for analysis. (D) Expression levels of pancreatic, hepatic (AFP), and intestinal (CDX2) marker genes at the end of stages 3 and 5 in cells differentiated under xeno-free conditions using xeno-free scaffolds (Synthemax, CELLstart, and rhVTN). The GAPDH transcript was amplified as internal RNA control. Results are presented as mean + SEM (n ¼ 3). Student's t-tests were performed against the values of Synthemax or between two discrete data sets. *P , 0.05, **P , 0.01. In vitro glucose-stimulated C-peptide secretion of differentiated cells at the end of stage 5 was determined by ELISA. C-peptide secretion levels under stimulation with 20 mM glucose were compared with those detected under treatment with 2.5 mM glucose. Fold increases are shown on the top of each pair of bars. The GAPDH transcript was used as internal RNA control. Expression levels of human adult pancreas genes were calculated and defined as 100. Results of both quantitative RT-PCR and ELISA are presented as mean + SEM (n ¼ 3). Student's t-tests were performed against the values of Toe unless specifically indicated, or between two discrete data sets for both gene expression and C-peptide content analyses, *P , 0.05, **P , 0.01. For glucose-stimulated C-peptide secretion, t-tests were performed against the values of 2.5 mM glucose treatment, *P , 0.05, **P , 0.01. AP, adult pancreas. Scale bar, 100 mm. and low levels of secreted C-peptide could be due to the generation of varying numbers of polyhormonal cells in the culture. The existence of polyhormonal cells has been reported during the primary transition stage of early fetal development in humans (De Krijger et al., 1992; Polak et al., 2000) . The role and fate of polyhormonal cells during human fetal development are poorly understood; however, immunohistochemical characterization indicated that these cells possess a-cell transcription factor profile . Previous studies reported that after transplantation, polyhormonal cells differentiated in vivo into GCG-expressing cells, and dynamic chromatin remodeling was reported to occur during this transition into matured cell types (Kelly et al., 2011; Rezania et al., 2011; Basford et al., 2012; Xie et al., 2013) . Recently, it has been shown that hES cell-derived pancreatic endoderm cells that were transplanted into immunodeficient mice underwent further differentiation and maturation into glucose-responsive INS-secreting cells (Kroon et al., 2008; Rezania et al., 2012 Rezania et al., , 2013 Animal-derived products are undesirable for clinical use. Therefore, in future clinical applications, hiPS cells must be generated, maintained, and differentiated in xeno-free culture systems to minimize the risk. We used xeno-free scaffolds, supplements, and growth factors without any feeder cells, for both maintenance and differentiation. However, to increase the safety of hiPS-based cell therapies, it would be extremely necessary to generate hiPS cells without integrating vectors and continuous c-MYC expression. The generation of hiPS cells with transient expression from nonintegrating vectors (Stadtfeld et al., 2008; Yu et al., 2009 ) may address these concerns.
To our knowledge, this is the first report of a complete xeno-free culture system in which hiPS cells have been differentiated into INS-positive cells. Indeed, our strategy provides evidence towards the possibility of differentiation of hiPS cells into pancreatic b-like cells without contamination by any non-human-derived factors. We believe that our differentiation strategy could be beneficial for the development of future cell therapies. Nevertheless, it also facilitates future in vitro studies on the mechanism of human pancreatic specialization and maturation.
Materials and methods
Cell lines
Toe, a hiPS cell line, was established from human embryonic lung cells by infection with retroviruses carrying OCT4, SOX2, KLF4, and C-MYC genes by Toyoda M., Kiyokawa N., Okita H., Miyagawa Y., Akutsu H., and Umezawa A. (National Institute for Child Health and Development, Tokyo; Yamazoe et al., 2013) . We obtained the Toe cell line from the cell bank of the National Institute of Biomedical Innovation, Japan. The cells were initially proliferated and maintained in an undifferentiated state under xenogeneic conditions up to P26 (passage 26) as described previously (Shiraki et al., 2008) and were freeze-stored at 21508C. We also used KhES3, a hES cell line, obtained from Drs Norio Nakatsuji and Hirofumi Suemori (Kyoto University); and 201B7, a hiPS cell line, obtained from Dr Shinya Yamanaka (Kyoto University). Undifferentiated KhES3 and 201B7 were also maintained as described (Shiraki et al., 2008) . Human ES cell study was approved by Kumamoto University's Institutional Review Board, following the hES cell guidelines of the Japanese government.
Xenogeneic and xeno-free undifferentiated hES/iPS cell culture
Freeze-stored hES/iPS cells were thawed and cultured on CellBIND cell culture dishes (Corning) coated with a xeno-free synthetic scaffold (Synthemax II-SC Substrate, functionalized with short peptide sequences derived from the vitronectin protein, which is covalently linked to the synthetic acrylate polymer, Corning) under feeder-free conditions with hES/iPS cell maintenance medium.
For xenogeneic culture, the maintenance medium was composed of Knockout DMEM/F12 (Life Technologies) supplemented with penicillin-streptomycin (50 units/ml penicillin, 50 mg/ml streptomycin [PS]; Nacalai Tesque), 2 mM L-glutamine (L-Gln; Nacalai Tesque), 1% nonessential amino acids (NEAA; Life Technologies), 0.1 mM 2-mercaptoethanol (2-ME; Sigma-Aldrich), 20% (v/v) knockout serum replacement (KSR; Life Technologies), and 5 ng/ml recombinant human FGF2 (rhFGF2; PeproTech) reconstituted with 0.1% bovine serum albumin (Sigma-Aldrich). Freeze-stored hiPS cells were grown with this maintenance medium for 3-4 days and used for xenogeneic differentiation ( Figure 1A) .
For xeno-free culture, KSR and rhFGF2 used in the xenogeneic maintenance medium were replaced with the KSR xeno-free Cell Therapy System (CTS; Life Technologies) and rhFGF2 reconstituted with 0.1% recombinant human albumin (Sigma-Aldrich), respectively. The medium was also supplemented with 1% KSR growth factor cocktail CTS (Life Technologies). Xeno-free maintenance medium is, therefore, free from animal-derived factors; rather, it contains all humanized and/or recombinant supplements and defined growth factors. Freeze-stored hES/iPS cells were first grown with xenogeneic maintenance medium for 3-4 days, and then sequentially passaged with xeno-free maintenance medium at a ratio of 1:3 every 3-4 days by dissociating cell colonies with a cell dissociation buffer (Life Technologies) before they were used for xeno-free differentiation ( Figure 1A) .
In vitro differentiation of undifferentiated hES/iPS cells
For pancreatic differentiation, undifferentiated hES/iPS cells were dissociated with TrypLE Select CTS (Life Technologies) after three consecutive passages under xeno-free conditions, seeded at a density of 1 × 10 5 cells/well on 96-well CellBIND cell culture plates coated with Synthemax II-SC Substrate. They were cultured for 1 day using xeno-free maintenance medium containing 10 mM ROCK inhibitor (Y-27632; Wako), followed by another 1-2 days of culture without ROCK inhibitor to 80%-90% confluence. Cells were directed through the following key stages of pancreatic development: DE cells (stage 1), PG cells (stage 2), PP cells (stage 3), EP cells (stage 4), and hormone-expressing ECs (stage 5) (Figure 2A) .
At stage 1, cells were cultured for 2 days in DMEM-high glucose (Life Technologies) supplemented with PS, 2 mM L-Gln, 1% NEAA, 0.1 mM 2-ME, 2% (v/v) B27 supplement xeno-free CTS (Life Technologies), 100 ng/ml recombinant human activin A (HumanZyme), and 3 mM CHIR99021 (TOCRIS Bioscience), and subsequently for another 3 days cultured without CHIR99021.
At stage 2, cells were cultured for 2 days in RPMI 1640 (Life Technologies) supplemented with PS, L-Gln, NEAA, 2-ME, B27 supplement xeno-free CTS, 0.25 mM KAAD-cyclopamine (Stemgent), and 50 ng/ml recombinant human FGF10 (PeproTech).
At stage 3, cells were cultured for 6 days in DMEM-high glucose supplemented with PS, L-Gln, NEAA, 2-ME, B27 supplement xenofree CTS, 2 mM all-trans RA (Stemgent), 0.25 mM Cyc, 10 mM SB431542 (CALBIOCHEM), and 200 ng/ml recombinant human NOGGIN (R&D Systems), with the media changed every 2 days.
At stage 4, cells were cultured for 2 days in DMEM-high glucose supplemented with PS, L-Gln, NEAA, 2-ME, B27 supplement xenofree CTS, 5 mM Alk5i (CALBIOCHEM), 300 nM (2) indolactam V (R&D Systems), and 200 ng/ml NOGGIN.
At stage 5, cells were cultured for 8 days in DMEM/F12 (Cell Science & Technology Inst.) supplemented with PS, L-Gln, NEAA, 2-ME, and B27 supplement xeno-free CTS. To this medium were added 50 ng/ml exendin-4 (Cell Sciences), 10 mM nicotinamide (Sigma-Aldrich), and/or 100 mM IBMX (Wako), and/or 10 mM FRKL (Wako). The media were changed every 2 days.
All factors were reconstituted using 0.1% recombinant human albumin, phosphate-buffered saline (PBS), or DMSO for xeno-free differentiation. A similar xeno-free technique for maintenance and differentiation of hiPS cells was used with the two other xenofree scaffolds, CELLstart (Life Technologies) and rhVTN (Life Technologies), to compare the differentiation efficiency with that achieved with the Synthemax II SC substrate.
Flow cytometry
Flow cytometry was performed for the xenoantigenic factor Neu5Gc, as described previously (Martin et al., 2005) . Briefly, 1.0 × 10 6 cells in a total volume of 50 ml were incubated at 48C for 60 min with a chicken anti-Neu5Gc IgY antibody (Ab) (1:200 dilution, Sialix), chicken IgY negative control (1:200 dilution, Sialix), or without a primary antibody. After three washes, cells were incubated at 48C for 60 min with an Alexa Fluor 488-conjugated donkey anti-chicken antibody (1:500, Molecular Probes). Flow cytometry was performed on a BD FACSCanto Flow Cytometer (BD Biosciences) and analyzed using the FlowJo software (Tree Star, Inc.).
Quantitative RT-PCR analysis
Total RNA was extracted from cells using TRIzol and genomic DNA contamination was removed by digestion with deoxyribonuclease I (Sigma-Aldrich). Total adult human pancreas RNA was purchased from Clontech. cDNA was prepared from 2.0 mg of RNA with oligo-dT primers and the ReverTraAce RT-reagent kit (TOYOBO). The primer sequences used for quantitative RT-PCR are summarized in Supplementary Table S1 . Quantitative RT-PCR was carried out on a 7500 FAST Real-Time PCR System (Applied Biosystems) using the Thunderbird Sybr qPCR Mix (TOYOBO). The expression of each target gene was normalized to the expression level of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Alkaline phosphatase staining
The cultured cells were fixed with 4% (w/v) paraformaldehyde (Nacalai Tesque), washed with PBS and then incubated with alkaline phosphatase buffer (100 mM Tris-HCl [pH 9.5], 100 mM NaCl, 50 mM MgCl 2 , and 0.1% Tween-20) for 30 min at room temperature. The staining reaction was carried out with 4-nitroblue tetrazolium chloride (35 mg/ml) and 5-bromo-4-chloro-3-indolyl phosphate (17.5 mg/ml) (Roche Diagnostics) in the dark for 30 min at room temperature. Cells were then washed with 1 mM EDTA/PBS, fixed with 4% paraformaldehyde, and images were captured.
Immunocytochemistry
Immunostaining was performed as described previously (Yamazoe et al., 2013) . Details on the primary antibodies are provided in Supplementary Table S2 . The secondary antibodies used were Alexa Fluor 488-, 568-, or 633-conjugated donkey or goat antimouse, anti-goat, anti-rabbit, anti-sheep, or anti-guinea pig IgG (1:1000 dilutions; Molecular Probes). Nuclei were counterstained with 4 ′ ,6-diamidino-2-phenylindole (DAPI, Roche Applied Science).
Images were captured using an ImageXpress Micro scanning system (Molecular Devices, Japan), and quantitative analysis was performed using the MetaXpress cellular image analysis software (Molecular Devices).
C-peptide release and content assay
The C-peptide release and content assay was performed as described previously (Sakano et al., 2014) with minor modifications. Briefly, differentiated cells at the end of stage 5 were pre-incubated at 378C for30 min with DMEM (Life Technologies) containing minimal essential medium, 1% B27 supplement, and 2.5 mM glucose. Cells were washed twice with PBS and then incubated at 378C for 1 h with DMEM containing 2.5 mM glucose at 100 ml per well. The culture medium was collected, and the same cells were further incubated with DMEM containing 20 mM glucose or DMEM containing 2.5 mM glucose supplemented with various stimulants, i.e. 2 mM (2)-Bay K8644 (Sigma-Aldrich), 100 mM tolbutamide (Wako), 250 mM carbachol (Sigma-Aldrich), 0.5 mM IBMX, or 30 mM potassium chloride (KCl) (Wako), at 378C for another 1 h. The culture media were collected and stored at 2208C until analysis. Next, the cells were lysed with lysis buffer (0.1% Triton X-100 in PBS) supplemented with 1% protease inhibitor cocktail (Nacalai Tesque). C-peptide secretion into the culture media and C-peptide content of the cell lysates were measured using the human C-peptide ELISA Kit (ALPCO Diagnostics). The amount of C-peptide was normalized to the amount of total protein in the corresponding cell lysate.
Statistical analyses
Data are expressed as mean + SEM (standard error of the mean). For comparisons of discrete data sets, unpaired Student's t-tests were performed. Significance levels or P-values are indicated in the figure legends.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
